4-(1H-naphtho[1,8-de][1,3,2]diazaborinin-2(3H)-yl)benzonitrile

Catalog No. :
ACZTBU801
CAS No. :
1670251-50-9
Molecular Formula :
C17H12BN3
Molecular Weight :
269.12

IUPAC Name:4-(1H-naphtho[1,8-de][1,3,2]diazaborinin-2(3H)-yl)benzonitrile

4-(1H-naphtho[1,8-de][1,3,2]diazaborinin-2(3H)-yl)benzonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(1H-naphtho[1,8-de][1,3,2]diazaborinin-2(3H)-yl)benzonitrile
IUPAC Name4-(1H-naphtho[1,8-de][1,3,2]diazaborinin-2(3H)-yl)benzonitrile
Molecular FormulaC17H12BN3
Molecular Weight269.12
SMILESN#CC1=CC=C(B2NC3=C4C(N2)=CC=CC4=CC=C3)C=C1
InChI KeyUSSPFXNVNMEDOI-UHFFFAOYSA-N
Synonym4-(1H-Naphtho[1,8-de]-1,3,2-diazaborin-2(3H)-yl)benzonitrile;Benzonitrile, 4-(1H-naphtho[1,8-de]-1,3,2-diazaborin-2(3H)-yl)-;4-(1H-Naphtho[1,8-de][1,3,2]diazaborinin-2(3H)-yl)benzonitrile
CAS No.1670251-50-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZTBU801 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKTQC218 route compound structure diagram
    ACKTQC218927384-44-9 In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACZTBU801 route product structure diagram
    ACZTBU8011670251-50-9
Inquiry

2. ACZTBU801 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKTQC218 route compound structure diagram
    ACKTQC218927384-44-9 In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACZTBU801 route product structure diagram
    ACZTBU8011670251-50-9
Inquiry

Comments (0)